RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
2.030
+0.030 (1.50%)
At close: May 12, 2025, 4:00 PM
2.100
+0.070 (3.45%)
After-hours: May 12, 2025, 5:41 PM EDT

RedHill Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-8.2723.92-71.67-97.74-76.17
Upgrade
Depreciation & Amortization
0.621.998.1518.158.75
Upgrade
Loss (Gain) From Sale of Investments
----0.09
Upgrade
Stock-Based Compensation
0.671.655.6810.214.2
Upgrade
Other Operating Activities
-4.44-47.7520.655.496.13
Upgrade
Change in Accounts Receivable
0.0531.93-2.85-3.02-27.44
Upgrade
Change in Inventory
0.742.393.8-8.29-4.64
Upgrade
Change in Accounts Payable
-2.11-0.95-7.430.117.37
Upgrade
Change in Other Net Operating Assets
3.37-48.9814.4910.0433.13
Upgrade
Operating Cash Flow
-9.37-35.82-29.19-65.05-48.58
Upgrade
Capital Expenditures
-0.01-0.01-0.2-0.12-0.41
Upgrade
Sale (Purchase) of Intangibles
-----53.37
Upgrade
Investment in Securities
-0.028.5-8.0318.13
Upgrade
Investing Cash Flow
-0.0108.3-8.14-35.65
Upgrade
Long-Term Debt Issued
----78.06
Upgrade
Long-Term Debt Repaid
-0.64-1.18-1.48-1.68-1.61
Upgrade
Net Debt Issued (Repaid)
-0.64-1.18-1.48-1.6876.45
Upgrade
Issuance of Common Stock
8.2613.9623.8182.5423.92
Upgrade
Other Financing Activities
0.798.66-10.88-7.4-16
Upgrade
Financing Cash Flow
8.4221.4411.4573.4684.37
Upgrade
Foreign Exchange Rate Adjustments
0.01-0.02-0.08-0.10.13
Upgrade
Net Cash Flow
-0.95-14.4-9.510.180.27
Upgrade
Free Cash Flow
-9.38-35.83-29.38-65.16-48.99
Upgrade
Free Cash Flow Margin
-116.60%-548.71%-47.55%-75.98%-76.11%
Upgrade
Free Cash Flow Per Share
-7.61-138.28-476.76-1400.52-1344.71
Upgrade
Cash Interest Paid
0.060.378.1811.286.65
Upgrade
Levered Free Cash Flow
-0.54-17.49-52.39-34.94-62.03
Upgrade
Unlevered Free Cash Flow
-0.5-17.26-26.56-24.58-54.25
Upgrade
Change in Net Working Capital
-5.886.613.422.12-26.38
Upgrade
Updated Aug 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q